Request for Covid-19 Impact Assessment of this Report
Geographically, this report split global into several key Regions, with sales (K Pcs), revenue (Million USD), market share and growth rate of Drugs for Osteoarthritis Pain for these regions, from 2012 to 2022 (forecast), covering
United States
China
Europe
Japan
Southeast Asia
India
Global Drugs for Osteoarthritis Pain market competition by top manufacturers/players, with Drugs for Osteoarthritis Pain sales volume, Price (USD/Pcs), revenue (Million USD) and market share for each manufacturer/player; the top players including
Abbott Laboratories
Johnson & Johnson
Novartis International
Pfizer
AbbVie
Abiogen Pharma
Afferent Pharmaceuticals
Astellas Pharma
BioDelivery Sciences International
Crystal Genomics
Cytori Therapeutics
Daiichi Sankyo
Eli Lilly
Endo Pharmaceuticals Holdings
Horizon Pharma
iCeutica
Iroko Pharmaceuticals
Merck
Nuvo Research
Regeneron Pharmaceuticals
Sanofi
SantoSolve
Techfields Pharma
Winston Pharmaceuticals
Yooyoung Pharmaceutical
Zynerba Pharmaceuticals
On the basis of product, this report displays the sales volume (K Pcs), revenue (Million USD), product price (USD/Pcs), market share and growth rate of each type, primarily split into
Solid
Liquid
Semi-solid
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Drugs for Osteoarthritis Pain for each application, including
Oral
Injection
External
If you have any special requirements, please let us know and we will offer you the report as you want.
Global Drugs for Osteoarthritis Pain Sales Market Report 2017
1 Drugs for Osteoarthritis Pain Market Overview
1.1 Product Overview and Scope of Drugs for Osteoarthritis Pain
1.2 Classification of Drugs for Osteoarthritis Pain by Product Category
1.2.1 Global Drugs for Osteoarthritis Pain Market Size (Sales) Comparison by Type (2012-2022)
1.2.2 Global Drugs for Osteoarthritis Pain Market Size (Sales) Market Share by Type (Product Category) in 2016
1.2.3 Solid
1.2.4 Liquid
1.2.5 Semi-solid
1.3 Global Drugs for Osteoarthritis Pain Market by Application/End Users
1.3.1 Global Drugs for Osteoarthritis Pain Sales (Volume) and Market Share Comparison by Application (2012-2022)
1.3.2 Oral
1.3.3 Injection
1.3.4 External
1.4 Global Drugs for Osteoarthritis Pain Market by Region
1.4.1 Global Drugs for Osteoarthritis Pain Market Size (Value) Comparison by Region (2012-2022)
1.4.2 United States Drugs for Osteoarthritis Pain Status and Prospect (2012-2022)
1.4.3 China Drugs for Osteoarthritis Pain Status and Prospect (2012-2022)
1.4.4 Europe Drugs for Osteoarthritis Pain Status and Prospect (2012-2022)
1.4.5 Japan Drugs for Osteoarthritis Pain Status and Prospect (2012-2022)
1.4.6 Southeast Asia Drugs for Osteoarthritis Pain Status and Prospect (2012-2022)
1.4.7 India Drugs for Osteoarthritis Pain Status and Prospect (2012-2022)
1.5 Global Market Size (Value and Volume) of Drugs for Osteoarthritis Pain (2012-2022)
1.5.1 Global Drugs for Osteoarthritis Pain Sales and Growth Rate (2012-2022)
1.5.2 Global Drugs for Osteoarthritis Pain Revenue and Growth Rate (2012-2022)
2 Global Drugs for Osteoarthritis Pain Competition by Players/Suppliers, Type and Application
2.1 Global Drugs for Osteoarthritis Pain Market Competition by Players/Suppliers
2.1.1 Global Drugs for Osteoarthritis Pain Sales and Market Share of Key Players/Suppliers (2012-2017)
2.1.2 Global Drugs for Osteoarthritis Pain Revenue and Share by Players/Suppliers (2012-2017)
2.2 Global Drugs for Osteoarthritis Pain (Volume and Value) by Type
2.2.1 Global Drugs for Osteoarthritis Pain Sales and Market Share by Type (2012-2017)
2.2.2 Global Drugs for Osteoarthritis Pain Revenue and Market Share by Type (2012-2017)
2.3 Global Drugs for Osteoarthritis Pain (Volume and Value) by Region
2.3.1 Global Drugs for Osteoarthritis Pain Sales and Market Share by Region (2012-2017)
2.3.2 Global Drugs for Osteoarthritis Pain Revenue and Market Share by Region (2012-2017)
2.4 Global Drugs for Osteoarthritis Pain (Volume) by Application
3 United States Drugs for Osteoarthritis Pain (Volume, Value and Sales Price)
3.1 United States Drugs for Osteoarthritis Pain Sales and Value (2012-2017)
3.1.1 United States Drugs for Osteoarthritis Pain Sales and Growth Rate (2012-2017)
3.1.2 United States Drugs for Osteoarthritis Pain Revenue and Growth Rate (2012-2017)
3.1.3 United States Drugs for Osteoarthritis Pain Sales Price Trend (2012-2017)
3.2 United States Drugs for Osteoarthritis Pain Sales Volume and Market Share by Players
3.3 United States Drugs for Osteoarthritis Pain Sales Volume and Market Share by Type
3.4 United States Drugs for Osteoarthritis Pain Sales Volume and Market Share by Application
4 China Drugs for Osteoarthritis Pain (Volume, Value and Sales Price)
4.1 China Drugs for Osteoarthritis Pain Sales and Value (2012-2017)
4.1.1 China Drugs for Osteoarthritis Pain Sales and Growth Rate (2012-2017)
4.1.2 China Drugs for Osteoarthritis Pain Revenue and Growth Rate (2012-2017)
4.1.3 China Drugs for Osteoarthritis Pain Sales Price Trend (2012-2017)
4.2 China Drugs for Osteoarthritis Pain Sales Volume and Market Share by Players
4.3 China Drugs for Osteoarthritis Pain Sales Volume and Market Share by Type
4.4 China Drugs for Osteoarthritis Pain Sales Volume and Market Share by Application
5 Europe Drugs for Osteoarthritis Pain (Volume, Value and Sales Price)
5.1 Europe Drugs for Osteoarthritis Pain Sales and Value (2012-2017)
5.1.1 Europe Drugs for Osteoarthritis Pain Sales and Growth Rate (2012-2017)
5.1.2 Europe Drugs for Osteoarthritis Pain Revenue and Growth Rate (2012-2017)
5.1.3 Europe Drugs for Osteoarthritis Pain Sales Price Trend (2012-2017)
5.2 Europe Drugs for Osteoarthritis Pain Sales Volume and Market Share by Players
5.3 Europe Drugs for Osteoarthritis Pain Sales Volume and Market Share by Type
5.4 Europe Drugs for Osteoarthritis Pain Sales Volume and Market Share by Application
6 Japan Drugs for Osteoarthritis Pain (Volume, Value and Sales Price)
6.1 Japan Drugs for Osteoarthritis Pain Sales and Value (2012-2017)
6.1.1 Japan Drugs for Osteoarthritis Pain Sales and Growth Rate (2012-2017)
6.1.2 Japan Drugs for Osteoarthritis Pain Revenue and Growth Rate (2012-2017)
6.1.3 Japan Drugs for Osteoarthritis Pain Sales Price Trend (2012-2017)
6.2 Japan Drugs for Osteoarthritis Pain Sales Volume and Market Share by Players
6.3 Japan Drugs for Osteoarthritis Pain Sales Volume and Market Share by Type
6.4 Japan Drugs for Osteoarthritis Pain Sales Volume and Market Share by Application
7 Southeast Asia Drugs for Osteoarthritis Pain (Volume, Value and Sales Price)
7.1 Southeast Asia Drugs for Osteoarthritis Pain Sales and Value (2012-2017)
7.1.1 Southeast Asia Drugs for Osteoarthritis Pain Sales and Growth Rate (2012-2017)
7.1.2 Southeast Asia Drugs for Osteoarthritis Pain Revenue and Growth Rate (2012-2017)
7.1.3 Southeast Asia Drugs for Osteoarthritis Pain Sales Price Trend (2012-2017)
7.2 Southeast Asia Drugs for Osteoarthritis Pain Sales Volume and Market Share by Players
7.3 Southeast Asia Drugs for Osteoarthritis Pain Sales Volume and Market Share by Type
7.4 Southeast Asia Drugs for Osteoarthritis Pain Sales Volume and Market Share by Application
8 India Drugs for Osteoarthritis Pain (Volume, Value and Sales Price)
8.1 India Drugs for Osteoarthritis Pain Sales and Value (2012-2017)
8.1.1 India Drugs for Osteoarthritis Pain Sales and Growth Rate (2012-2017)
8.1.2 India Drugs for Osteoarthritis Pain Revenue and Growth Rate (2012-2017)
8.1.3 India Drugs for Osteoarthritis Pain Sales Price Trend (2012-2017)
8.2 India Drugs for Osteoarthritis Pain Sales Volume and Market Share by Players
8.3 India Drugs for Osteoarthritis Pain Sales Volume and Market Share by Type
8.4 India Drugs for Osteoarthritis Pain Sales Volume and Market Share by Application
9 Global Drugs for Osteoarthritis Pain Players/Suppliers Profiles and Sales Data
9.1 Abbott Laboratories
9.1.1 Company Basic Information, Manufacturing Base and Competitors
9.1.2 Drugs for Osteoarthritis Pain Product Category, Application and Specification
9.1.2.1 Product A
9.1.2.2 Product B
9.1.3 Abbott Laboratories Drugs for Osteoarthritis Pain Sales, Revenue, Price and Gross Margin (2012-2017)
9.1.4 Main Business/Business Overview
9.2 Johnson & Johnson
9.2.1 Company Basic Information, Manufacturing Base and Competitors
9.2.2 Drugs for Osteoarthritis Pain Product Category, Application and Specification
9.2.2.1 Product A
9.2.2.2 Product B
9.2.3 Johnson & Johnson Drugs for Osteoarthritis Pain Sales, Revenue, Price and Gross Margin (2012-2017)
9.2.4 Main Business/Business Overview
9.3 Novartis International
9.3.1 Company Basic Information, Manufacturing Base and Competitors
9.3.2 Drugs for Osteoarthritis Pain Product Category, Application and Specification
9.3.2.1 Product A
9.3.2.2 Product B
9.3.3 Novartis International Drugs for Osteoarthritis Pain Sales, Revenue, Price and Gross Margin (2012-2017)
9.3.4 Main Business/Business Overview
9.4 Pfizer
9.4.1 Company Basic Information, Manufacturing Base and Competitors
9.4.2 Drugs for Osteoarthritis Pain Product Category, Application and Specification
9.4.2.1 Product A
9.4.2.2 Product B
9.4.3 Pfizer Drugs for Osteoarthritis Pain Sales, Revenue, Price and Gross Margin (2012-2017)
9.4.4 Main Business/Business Overview
9.5 AbbVie
9.5.1 Company Basic Information, Manufacturing Base and Competitors
9.5.2 Drugs for Osteoarthritis Pain Product Category, Application and Specification
9.5.2.1 Product A
9.5.2.2 Product B
9.5.3 AbbVie Drugs for Osteoarthritis Pain Sales, Revenue, Price and Gross Margin (2012-2017)
9.5.4 Main Business/Business Overview
9.6 Abiogen Pharma
9.6.1 Company Basic Information, Manufacturing Base and Competitors
9.6.2 Drugs for Osteoarthritis Pain Product Category, Application and Specification
9.6.2.1 Product A
9.6.2.2 Product B
9.6.3 Abiogen Pharma Drugs for Osteoarthritis Pain Sales, Revenue, Price and Gross Margin (2012-2017)
9.6.4 Main Business/Business Overview
9.7 Afferent Pharmaceuticals
9.7.1 Company Basic Information, Manufacturing Base and Competitors
9.7.2 Drugs for Osteoarthritis Pain Product Category, Application and Specification
9.7.2.1 Product A
9.7.2.2 Product B
9.7.3 Afferent Pharmaceuticals Drugs for Osteoarthritis Pain Sales, Revenue, Price and Gross Margin (2012-2017)
9.7.4 Main Business/Business Overview
9.8 Astellas Pharma
9.8.1 Company Basic Information, Manufacturing Base and Competitors
9.8.2 Drugs for Osteoarthritis Pain Product Category, Application and Specification
9.8.2.1 Product A
9.8.2.2 Product B
9.8.3 Astellas Pharma Drugs for Osteoarthritis Pain Sales, Revenue, Price and Gross Margin (2012-2017)
9.8.4 Main Business/Business Overview
9.9 BioDelivery Sciences International
9.9.1 Company Basic Information, Manufacturing Base and Competitors
9.9.2 Drugs for Osteoarthritis Pain Product Category, Application and Specification
9.9.2.1 Product A
9.9.2.2 Product B
9.9.3 BioDelivery Sciences International Drugs for Osteoarthritis Pain Sales, Revenue, Price and Gross Margin (2012-2017)
9.9.4 Main Business/Business Overview
9.10 Crystal Genomics
9.10.1 Company Basic Information, Manufacturing Base and Competitors
9.10.2 Drugs for Osteoarthritis Pain Product Category, Application and Specification
9.10.2.1 Product A
9.10.2.2 Product B
9.10.3 Crystal Genomics Drugs for Osteoarthritis Pain Sales, Revenue, Price and Gross Margin (2012-2017)
9.10.4 Main Business/Business Overview
9.11 Cytori Therapeutics
9.12 Daiichi Sankyo
9.13 Eli Lilly
9.14 Endo Pharmaceuticals Holdings
9.15 Horizon Pharma
9.16 iCeutica
9.17 Iroko Pharmaceuticals
9.18 Merck
9.19 Nuvo Research
9.20 Regeneron Pharmaceuticals
9.21 Sanofi
9.22 SantoSolve
9.23 Techfields Pharma
9.24 Winston Pharmaceuticals
9.25 Yooyoung Pharmaceutical
9.26 Zynerba Pharmaceuticals
10 Drugs for Osteoarthritis Pain Maufacturing Cost Analysis
10.1 Drugs for Osteoarthritis Pain Key Raw Materials Analysis
10.1.1 Key Raw Materials
10.1.2 Price Trend of Key Raw Materials
10.1.3 Key Suppliers of Raw Materials
10.1.4 Market Concentration Rate of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
10.2.1 Raw Materials
10.2.2 Labor Cost
10.2.3 Manufacturing Process Analysis of Drugs for Osteoarthritis Pain
10.3 Manufacturing Process Analysis of Drugs for Osteoarthritis Pain
11 Industrial Chain, Sourcing Strategy and Downstream Buyers
11.1 Drugs for Osteoarthritis Pain Industrial Chain Analysis
11.2 Upstream Raw Materials Sourcing
11.3 Raw Materials Sources of Drugs for Osteoarthritis Pain Major Manufacturers in 2016
11.4 Downstream Buyers
12 Marketing Strategy Analysis, Distributors/Traders
12.1 Marketing Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
12.2.1 Pricing Strategy
12.2.2 Brand Strategy
12.2.3 Target Client
12.3 Distributors/Traders List
13 Market Effect Factors Analysis
13.1 Technology Progress/Risk
13.1.1 Substitutes Threat
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs/Customer Preference Change
13.3 Economic/Political Environmental Change
14 Global Drugs for Osteoarthritis Pain Market Forecast (2017-2022)
14.1 Global Drugs for Osteoarthritis Pain Sales Volume, Revenue and Price Forecast (2017-2022)
14.1.1 Global Drugs for Osteoarthritis Pain Sales Volume and Growth Rate Forecast (2017-2022)
14.1.2 Global Drugs for Osteoarthritis Pain Revenue and Growth Rate Forecast (2017-2022)
14.1.3 Global Drugs for Osteoarthritis Pain Price and Trend Forecast (2017-2022)
14.2 Global Drugs for Osteoarthritis Pain Sales Volume, Revenue and Growth Rate Forecast by Region (2017-2022)
14.2.1 Global Drugs for Osteoarthritis Pain Sales Volume and Growth Rate Forecast by Regions (2017-2022)
14.2.2 Global Drugs for Osteoarthritis Pain Revenue and Growth Rate Forecast by Regions (2017-2022)
14.2.3 United States Drugs for Osteoarthritis Pain Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.2.4 China Drugs for Osteoarthritis Pain Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.2.5 Europe Drugs for Osteoarthritis Pain Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.2.6 Japan Drugs for Osteoarthritis Pain Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.2.7 Southeast Asia Drugs for Osteoarthritis Pain Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.2.8 India Drugs for Osteoarthritis Pain Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.3 Global Drugs for Osteoarthritis Pain Sales Volume, Revenue and Price Forecast by Type (2017-2022)
14.3.1 Global Drugs for Osteoarthritis Pain Sales Forecast by Type (2017-2022)
14.3.2 Global Drugs for Osteoarthritis Pain Revenue Forecast by Type (2017-2022)
14.3.3 Global Drugs for Osteoarthritis Pain Price Forecast by Type (2017-2022)
14.4 Global Drugs for Osteoarthritis Pain Sales Volume Forecast by Application (2017-2022)
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Disclaimer
Figure Product Picture of Drugs for Osteoarthritis Pain
Figure Global Drugs for Osteoarthritis Pain Sales Volume Comparison (K Pcs) by Type (2012-2022)
Figure Global Drugs for Osteoarthritis Pain Sales Volume Market Share by Type (Product Category) in 2016
Figure Solid Product Picture
Figure Liquid Product Picture
Figure Semi-solid Product Picture
Figure Global Drugs for Osteoarthritis Pain Sales Comparison (K Pcs) by Application (2012-2022)
Figure Global Sales Market Share of Drugs for Osteoarthritis Pain by Application in 2016
Figure Oral Examples
Figure Injection Examples
Figure External Examples
Figure Global Drugs for Osteoarthritis Pain Market Size (Million USD) by Regions (2012-2022)
Figure United States Drugs for Osteoarthritis Pain Revenue (Million USD) and Growth Rate (2012-2022)
Figure China Drugs for Osteoarthritis Pain Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Drugs for Osteoarthritis Pain Revenue (Million USD) and Growth Rate (2012-2022)
Figure Japan Drugs for Osteoarthritis Pain Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southeast Asia Drugs for Osteoarthritis Pain Revenue (Million USD) and Growth Rate (2012-2022)
Figure India Drugs for Osteoarthritis Pain Revenue (Million USD) and Growth Rate (2012-2022)
Figure Global Drugs for Osteoarthritis Pain Sales Volume (K Pcs) and Growth Rate (2012-2022)
Figure Global Drugs for Osteoarthritis Pain Revenue (Million USD) and Growth Rate (2012-2022)
Figure Global Market Major Players Drugs for Osteoarthritis Pain Sales Volume (K Pcs) (2012-2017)
Table Global Drugs for Osteoarthritis Pain Sales (K Pcs) of Key Players/Suppliers (2012-2017)
Table Global Drugs for Osteoarthritis Pain Sales Share by Players/Suppliers (2012-2017)
Figure 2016 Drugs for Osteoarthritis Pain Sales Share by Players/Suppliers
Figure 2017 Drugs for Osteoarthritis Pain Sales Share by Players/Suppliers
Figure Global Drugs for Osteoarthritis Pain Revenue (Million USD) by Players/Suppliers (2012-2017)
Table Global Drugs for Osteoarthritis Pain Revenue (Million USD) by Players/Suppliers (2012-2017)
Table Global Drugs for Osteoarthritis Pain Revenue Share by Players/Suppliers (2012-2017)
Table 2016 Global Drugs for Osteoarthritis Pain Revenue Share by Players
Table 2017 Global Drugs for Osteoarthritis Pain Revenue Share by Players
Table Global Drugs for Osteoarthritis Pain Sales (K Pcs) and Market Share by Type (2012-2017)
Table Global Drugs for Osteoarthritis Pain Sales Share (K Pcs) by Type (2012-2017)
Figure Sales Market Share of Drugs for Osteoarthritis Pain by Type (2012-2017)
Figure Global Drugs for Osteoarthritis Pain Sales Growth Rate by Type (2012-2017)
Table Global Drugs for Osteoarthritis Pain Revenue (Million USD) and Market Share by Type (2012-2017)
Table Global Drugs for Osteoarthritis Pain Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Drugs for Osteoarthritis Pain by Type (2012-2017)
Figure Global Drugs for Osteoarthritis Pain Revenue Growth Rate by Type (2012-2017)
Table Global Drugs for Osteoarthritis Pain Sales Volume (K Pcs) and Market Share by Region (2012-2017)
Table Global Drugs for Osteoarthritis Pain Sales Share by Region (2012-2017)
Figure Sales Market Share of Drugs for Osteoarthritis Pain by Region (2012-2017)
Figure Global Drugs for Osteoarthritis Pain Sales Growth Rate by Region in 2016
Table Global Drugs for Osteoarthritis Pain Revenue (Million USD) and Market Share by Region (2012-2017)
Table Global Drugs for Osteoarthritis Pain Revenue Share (%) by Region (2012-2017)
Figure Revenue Market Share of Drugs for Osteoarthritis Pain by Region (2012-2017)
Figure Global Drugs for Osteoarthritis Pain Revenue Growth Rate by Region in 2016
Table Global Drugs for Osteoarthritis Pain Revenue (Million USD) and Market Share by Region (2012-2017)
Table Global Drugs for Osteoarthritis Pain Revenue Share (%) by Region (2012-2017)
Figure Revenue Market Share of Drugs for Osteoarthritis Pain by Region (2012-2017)
Figure Global Drugs for Osteoarthritis Pain Revenue Market Share by Region in 2016
Table Global Drugs for Osteoarthritis Pain Sales Volume (K Pcs) and Market Share by Application (2012-2017)
Table Global Drugs for Osteoarthritis Pain Sales Share (%) by Application (2012-2017)
Figure Sales Market Share of Drugs for Osteoarthritis Pain by Application (2012-2017)
Figure Global Drugs for Osteoarthritis Pain Sales Market Share by Application (2012-2017)
Figure United States Drugs for Osteoarthritis Pain Sales (K Pcs) and Growth Rate (2012-2017)
Figure United States Drugs for Osteoarthritis Pain Revenue (Million USD) and Growth Rate (2012-2017)
Figure United States Drugs for Osteoarthritis Pain Sales Price (USD/Pcs) Trend (2012-2017)
Table United States Drugs for Osteoarthritis Pain Sales Volume (K Pcs) by Players (2012-2017)
Table United States Drugs for Osteoarthritis Pain Sales Volume Market Share by Players (2012-2017)
Figure United States Drugs for Osteoarthritis Pain Sales Volume Market Share by Players in 2016
Table United States Drugs for Osteoarthritis Pain Sales Volume (K Pcs) by Type (2012-2017)
Table United States Drugs for Osteoarthritis Pain Sales Volume Market Share by Type (2012-2017)
Figure United States Drugs for Osteoarthritis Pain Sales Volume Market Share by Type in 2016
Table United States Drugs for Osteoarthritis Pain Sales Volume (K Pcs) by Application (2012-2017)
Table United States Drugs for Osteoarthritis Pain Sales Volume Market Share by Application (2012-2017)
Figure United States Drugs for Osteoarthritis Pain Sales Volume Market Share by Application in 2016
Figure China Drugs for Osteoarthritis Pain Sales (K Pcs) and Growth Rate (2012-2017)
Figure China Drugs for Osteoarthritis Pain Revenue (Million USD) and Growth Rate (2012-2017)
Figure China Drugs for Osteoarthritis Pain Sales Price (USD/Pcs) Trend (2012-2017)
Table China Drugs for Osteoarthritis Pain Sales Volume (K Pcs) by Players (2012-2017)
Table China Drugs for Osteoarthritis Pain Sales Volume Market Share by Players (2012-2017)
Figure China Drugs for Osteoarthritis Pain Sales Volume Market Share by Players in 2016
Table China Drugs for Osteoarthritis Pain Sales Volume (K Pcs) by Type (2012-2017)
Table China Drugs for Osteoarthritis Pain Sales Volume Market Share by Type (2012-2017)
Figure China Drugs for Osteoarthritis Pain Sales Volume Market Share by Type in 2016
Table China Drugs for Osteoarthritis Pain Sales Volume (K Pcs) by Application (2012-2017)
Table China Drugs for Osteoarthritis Pain Sales Volume Market Share by Application (2012-2017)
Figure China Drugs for Osteoarthritis Pain Sales Volume Market Share by Application in 2016
Figure Europe Drugs for Osteoarthritis Pain Sales (K Pcs) and Growth Rate (2012-2017)
Figure Europe Drugs for Osteoarthritis Pain Revenue (Million USD) and Growth Rate (2012-2017)
Figure Europe Drugs for Osteoarthritis Pain Sales Price (USD/Pcs) Trend (2012-2017)
Table Europe Drugs for Osteoarthritis Pain Sales Volume (K Pcs) by Players (2012-2017)
Table Europe Drugs for Osteoarthritis Pain Sales Volume Market Share by Players (2012-2017)
Figure Europe Drugs for Osteoarthritis Pain Sales Volume Market Share by Players in 2016
Table Europe Drugs for Osteoarthritis Pain Sales Volume (K Pcs) by Type (2012-2017)
Table Europe Drugs for Osteoarthritis Pain Sales Volume Market Share by Type (2012-2017)
Figure Europe Drugs for Osteoarthritis Pain Sales Volume Market Share by Type in 2016
Table Europe Drugs for Osteoarthritis Pain Sales Volume (K Pcs) by Application (2012-2017)
Table Europe Drugs for Osteoarthritis Pain Sales Volume Market Share by Application (2012-2017)
Figure Europe Drugs for Osteoarthritis Pain Sales Volume Market Share by Application in 2016
Figure Japan Drugs for Osteoarthritis Pain Sales (K Pcs) and Growth Rate (2012-2017)
Figure Japan Drugs for Osteoarthritis Pain Revenue (Million USD) and Growth Rate (2012-2017)
Figure Japan Drugs for Osteoarthritis Pain Sales Price (USD/Pcs) Trend (2012-2017)
Table Japan Drugs for Osteoarthritis Pain Sales Volume (K Pcs) by Players (2012-2017)
Table Japan Drugs for Osteoarthritis Pain Sales Volume Market Share by Players (2012-2017)
Figure Japan Drugs for Osteoarthritis Pain Sales Volume Market Share by Players in 2016
Table Japan Drugs for Osteoarthritis Pain Sales Volume (K Pcs) by Type (2012-2017)
Table Japan Drugs for Osteoarthritis Pain Sales Volume Market Share by Type (2012-2017)
Figure Japan Drugs for Osteoarthritis Pain Sales Volume Market Share by Type in 2016
Table Japan Drugs for Osteoarthritis Pain Sales Volume (K Pcs) by Application (2012-2017)
Table Japan Drugs for Osteoarthritis Pain Sales Volume Market Share by Application (2012-2017)
Figure Japan Drugs for Osteoarthritis Pain Sales Volume Market Share by Application in 2016
Figure Southeast Asia Drugs for Osteoarthritis Pain Sales (K Pcs) and Growth Rate (2012-2017)
Figure Southeast Asia Drugs for Osteoarthritis Pain Revenue (Million USD) and Growth Rate (2012-2017)
Figure Southeast Asia Drugs for Osteoarthritis Pain Sales Price (USD/Pcs) Trend (2012-2017)
Table Southeast Asia Drugs for Osteoarthritis Pain Sales Volume (K Pcs) by Players (2012-2017)
Table Southeast Asia Drugs for Osteoarthritis Pain Sales Volume Market Share by Players (2012-2017)
Figure Southeast Asia Drugs for Osteoarthritis Pain Sales Volume Market Share by Players in 2016
Table Southeast Asia Drugs for Osteoarthritis Pain Sales Volume (K Pcs) by Type (2012-2017)
Table Southeast Asia Drugs for Osteoarthritis Pain Sales Volume Market Share by Type (2012-2017)
Figure Southeast Asia Drugs for Osteoarthritis Pain Sales Volume Market Share by Type in 2016
Table Southeast Asia Drugs for Osteoarthritis Pain Sales Volume (K Pcs) by Application (2012-2017)
Table Southeast Asia Drugs for Osteoarthritis Pain Sales Volume Market Share by Application (2012-2017)
Figure Southeast Asia Drugs for Osteoarthritis Pain Sales Volume Market Share by Application in 2016
Figure India Drugs for Osteoarthritis Pain Sales (K Pcs) and Growth Rate (2012-2017)
Figure India Drugs for Osteoarthritis Pain Revenue (Million USD) and Growth Rate (2012-2017)
Figure India Drugs for Osteoarthritis Pain Sales Price (USD/Pcs) Trend (2012-2017)
Table India Drugs for Osteoarthritis Pain Sales Volume (K Pcs) by Players (2012-2017)
Table India Drugs for Osteoarthritis Pain Sales Volume Market Share by Players (2012-2017)
Figure India Drugs for Osteoarthritis Pain Sales Volume Market Share by Players in 2016
Table India Drugs for Osteoarthritis Pain Sales Volume (K Pcs) by Type (2012-2017)
Table India Drugs for Osteoarthritis Pain Sales Volume Market Share by Type (2012-2017)
Figure India Drugs for Osteoarthritis Pain Sales Volume Market Share by Type in 2016
Table India Drugs for Osteoarthritis Pain Sales Volume (K Pcs) by Application (2012-2017)
Table India Drugs for Osteoarthritis Pain Sales Volume Market Share by Application (2012-2017)
Figure India Drugs for Osteoarthritis Pain Sales Volume Market Share by Application in 2016
Table Abbott Laboratories Basic Information List
Table Abbott Laboratories Drugs for Osteoarthritis Pain Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Abbott Laboratories Drugs for Osteoarthritis Pain Sales Growth Rate (2012-2017)
Figure Abbott Laboratories Drugs for Osteoarthritis Pain Sales Global Market Share (2012-2017
Figure Abbott Laboratories Drugs for Osteoarthritis Pain Revenue Global Market Share (2012-2017)
Table Johnson & Johnson Basic Information List
Table Johnson & Johnson Drugs for Osteoarthritis Pain Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Johnson & Johnson Drugs for Osteoarthritis Pain Sales Growth Rate (2012-2017)
Figure Johnson & Johnson Drugs for Osteoarthritis Pain Sales Global Market Share (2012-2017
Figure Johnson & Johnson Drugs for Osteoarthritis Pain Revenue Global Market Share (2012-2017)
Table Novartis International Basic Information List
Table Novartis International Drugs for Osteoarthritis Pain Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Novartis International Drugs for Osteoarthritis Pain Sales Growth Rate (2012-2017)
Figure Novartis International Drugs for Osteoarthritis Pain Sales Global Market Share (2012-2017
Figure Novartis International Drugs for Osteoarthritis Pain Revenue Global Market Share (2012-2017)
Table Pfizer Basic Information List
Table Pfizer Drugs for Osteoarthritis Pain Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Pfizer Drugs for Osteoarthritis Pain Sales Growth Rate (2012-2017)
Figure Pfizer Drugs for Osteoarthritis Pain Sales Global Market Share (2012-2017
Figure Pfizer Drugs for Osteoarthritis Pain Revenue Global Market Share (2012-2017)
Table AbbVie Basic Information List
Table AbbVie Drugs for Osteoarthritis Pain Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure AbbVie Drugs for Osteoarthritis Pain Sales Growth Rate (2012-2017)
Figure AbbVie Drugs for Osteoarthritis Pain Sales Global Market Share (2012-2017
Figure AbbVie Drugs for Osteoarthritis Pain Revenue Global Market Share (2012-2017)
Table Abiogen Pharma Basic Information List
Table Abiogen Pharma Drugs for Osteoarthritis Pain Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Abiogen Pharma Drugs for Osteoarthritis Pain Sales Growth Rate (2012-2017)
Figure Abiogen Pharma Drugs for Osteoarthritis Pain Sales Global Market Share (2012-2017
Figure Abiogen Pharma Drugs for Osteoarthritis Pain Revenue Global Market Share (2012-2017)
Table Afferent Pharmaceuticals Basic Information List
Table Afferent Pharmaceuticals Drugs for Osteoarthritis Pain Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Afferent Pharmaceuticals Drugs for Osteoarthritis Pain Sales Growth Rate (2012-2017)
Figure Afferent Pharmaceuticals Drugs for Osteoarthritis Pain Sales Global Market Share (2012-2017
Figure Afferent Pharmaceuticals Drugs for Osteoarthritis Pain Revenue Global Market Share (2012-2017)
Table Astellas Pharma Basic Information List
Table Astellas Pharma Drugs for Osteoarthritis Pain Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Astellas Pharma Drugs for Osteoarthritis Pain Sales Growth Rate (2012-2017)
Figure Astellas Pharma Drugs for Osteoarthritis Pain Sales Global Market Share (2012-2017
Figure Astellas Pharma Drugs for Osteoarthritis Pain Revenue Global Market Share (2012-2017)
Table BioDelivery Sciences International Basic Information List
Table BioDelivery Sciences International Drugs for Osteoarthritis Pain Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure BioDelivery Sciences International Drugs for Osteoarthritis Pain Sales Growth Rate (2012-2017)
Figure BioDelivery Sciences International Drugs for Osteoarthritis Pain Sales Global Market Share (2012-2017
Figure BioDelivery Sciences International Drugs for Osteoarthritis Pain Revenue Global Market Share (2012-2017)
Table Crystal Genomics Basic Information List
Table Crystal Genomics Drugs for Osteoarthritis Pain Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Crystal Genomics Drugs for Osteoarthritis Pain Sales Growth Rate (2012-2017)
Figure Crystal Genomics Drugs for Osteoarthritis Pain Sales Global Market Share (2012-2017
Figure Crystal Genomics Drugs for Osteoarthritis Pain Revenue Global Market Share (2012-2017)
Table Cytori Therapeutics Basic Information List
Table Daiichi Sankyo Basic Information List
Table Eli Lilly Basic Information List
Table Endo Pharmaceuticals Holdings Basic Information List
Table Horizon Pharma Basic Information List
Table iCeutica Basic Information List
Table Iroko Pharmaceuticals Basic Information List
Table Merck Basic Information List
Table Nuvo Research Basic Information List
Table Regeneron Pharmaceuticals Basic Information List
Table Sanofi Basic Information List
Table SantoSolve Basic Information List
Table Techfields Pharma Basic Information List
Table Winston Pharmaceuticals Basic Information List
Table Yooyoung Pharmaceutical Basic Information List
Table Zynerba Pharmaceuticals Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Drugs for Osteoarthritis Pain
Figure Manufacturing Process Analysis of Drugs for Osteoarthritis Pain
Figure Drugs for Osteoarthritis Pain Industrial Chain Analysis
Table Raw Materials Sources of Drugs for Osteoarthritis Pain Major Players in 2016
Table Major Buyers of Drugs for Osteoarthritis Pain
Table Distributors/Traders List
Figure Global Drugs for Osteoarthritis Pain Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure Global Drugs for Osteoarthritis Pain Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Global Drugs for Osteoarthritis Pain Price (USD/Pcs) and Trend Forecast (2017-2022)
Table Global Drugs for Osteoarthritis Pain Sales Volume (K Pcs) Forecast by Regions (2017-2022)
Figure Global Drugs for Osteoarthritis Pain Sales Volume Market Share Forecast by Regions (2017-2022)
Figure Global Drugs for Osteoarthritis Pain Sales Volume Market Share Forecast by Regions in 2022
Table Global Drugs for Osteoarthritis Pain Revenue (Million USD) Forecast by Regions (2017-2022)
Figure Global Drugs for Osteoarthritis Pain Revenue Market Share Forecast by Regions (2017-2022)
Figure Global Drugs for Osteoarthritis Pain Revenue Market Share Forecast by Regions in 2022
Figure United States Drugs for Osteoarthritis Pain Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure United States Drugs for Osteoarthritis Pain Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure China Drugs for Osteoarthritis Pain Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure China Drugs for Osteoarthritis Pain Revenue and Growth Rate Forecast (2017-2022)
Figure Europe Drugs for Osteoarthritis Pain Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure Europe Drugs for Osteoarthritis Pain Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Japan Drugs for Osteoarthritis Pain Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure Japan Drugs for Osteoarthritis Pain Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Drugs for Osteoarthritis Pain Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Drugs for Osteoarthritis Pain Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure India Drugs for Osteoarthritis Pain Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure India Drugs for Osteoarthritis Pain Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Global Drugs for Osteoarthritis Pain Sales (K Pcs) Forecast by Type (2017-2022)
Figure Global Drugs for Osteoarthritis Pain Sales Volume Market Share Forecast by Type (2017-2022)
Table Global Drugs for Osteoarthritis Pain Revenue (Million USD) Forecast by Type (2017-2022)
Figure Global Drugs for Osteoarthritis Pain Revenue Market Share Forecast by Type (2017-2022)
Table Global Drugs for Osteoarthritis Pain Price (USD/Pcs) Forecast by Type (2017-2022)
Table Global Drugs for Osteoarthritis Pain Sales (K Pcs) Forecast by Application (2017-2022)
Figure Global Drugs for Osteoarthritis Pain Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...
Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...
The pharmaceutical agents that are administered to treat, diagnose, and prevent life-threatening diseases (rare diseases) are known as orphan drugs. The global orphan drugs market accounted for $106 billion in 2015, and is anticipated to reach $169 billio...